Trials / Conditions / Chemotherapy-induced Peripheral Neuropathy

Chemotherapy-induced Peripheral Neuropathy

180 registered clinical trials studyying Chemotherapy-induced Peripheral Neuropathy — 48 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	CBG/CBD Oil for Chemotherapy-Induced Peripheral Neuropathy NCT07016971	Milton S. Hershey Medical Center	Phase 1
Recruiting	Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy NCT07219472	Case Comprehensive Cancer Center	N/A
Recruiting	A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neurop NCT07365007	University of Michigan Rogel Cancer Center	N/A
Not Yet Recruiting	The Influence of Chemotherapy on Position Sense NCT07367711	KU Leuven	—
Not Yet Recruiting	Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2026 and 2029. NCT07325851	Bernardino Clavo, MD, PhD	—
Recruiting	VGAIT for Chemotherapy-induced Peripheral Neuropathy NCT07177820	Massachusetts General Hospital	N/A
Not Yet Recruiting	8 Weeks vs 12 Weeks Physical Exercise Programmes in Colorectal Cancer Patients NCT07307690	University of Salamanca	N/A
Recruiting	Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN) NCT07072468	VM Therapeutics LLC	Phase 2
Recruiting	Cryocompression for CIPN NCT07064798	Dana-Farber Cancer Institute	N/A
Recruiting	Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer S NCT06731894	City of Hope Medical Center	Phase 2
Not Yet Recruiting	Neurocognitive and Psychological Impact of Chemotherapy in Breast Cancer Patients: A Prospective Observational NCT07184749	Sohag University	—
Not Yet Recruiting	Tibial Nerve Elastography in Chemotherapy-Induced Neuropathic Pain NCT07048431	Ankara Etlik City Hospital	—
Not Yet Recruiting	Safety and Efficacy Study of TAR-0520 Gel in Prevention of Taxane-induced Peripheral Neuropathy NCT07082764	Tarian Pharma	Phase 2
Recruiting	Compression Stockings to Prevent Peripheral Neuropathy Caused by Antibody-Drug Conjugates in Urothelial Carcin NCT07164950	Sheng Zhang	N/A
Recruiting	Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors NCT07019259	Yale University	N/A
Enrolling By Invitation	Helping Cancer Patients Manage Neuropathy Symptoms From Chemotherapy With a Low-Intensity, Low-Risk Cranial PE NCT07061769	FluxWear, INC	N/A
Recruiting	Evaluating a Mobile Health Application Intervention for Caregiver Instruction in Manual Therapy for Chemothera NCT06945380	Mayo Clinic	N/A
Recruiting	Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy NCT05786599	University of British Columbia	Phase 2 / Phase 3
Not Yet Recruiting	Neural and Immune Correlates of CIPN and Possible Analgesic Effect of Non-invasive Motor Cortex Stimulation NCT06522685	Morgan State University	N/A
Recruiting	The Use of Acupuncture to Reduce Chemotherapy Induced Peripheral Neuropathy in Gynaecological Cancer Patients NCT06769061	Karen Kar Loen CHAN	N/A
Not Yet Recruiting	Sensory Rehabilitation in Chemo Induced Peripheral Neuropathy NCT06724861	Assaf-Harofeh Medical Center	N/A
Not Yet Recruiting	Effects of Telerehabilitation Versus Clinical Rehabilitation on Chemotherapy Induced Peripheral Neuropathy NCT06696976	Riphah International University	N/A
Recruiting	Clinical Biomarker of Paclitaxel-induced Peripheral Neuropathy NCT06430814	University of Southern Denmark	—
Not Yet Recruiting	Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy NCT06596200	University of Maryland St. Joseph Medical Center	Phase 4
Completed	Real-World Pharmacological Treatment Pattern of Neuropathic Pain in China NCT06546202	Daiichi Sankyo	—
Recruiting	Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy NCT06389721	M.D. Anderson Cancer Center	—
Withdrawn	Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon NCT05672342	City of Hope Medical Center	EARLY_Phase 1
Not Yet Recruiting	Effects of a Strength Physical Exercise Program in Colorectal Cancer Patients Undergoing Chemotherapy Treatmen NCT06404359	Juan Luis Sanchez Gonzalez	N/A
Withdrawn	Evaluation of Hydroxychloroquine to Prevent CIPN NCT05689359	University of Arizona	Phase 2
Active Not Recruiting	Exercise-based Rehabilitation to Treat Persistent Chemotherapy Induced Peripheral Neuropathy (CIPN) NCT06405542	University Health Network, Toronto	Phase 1
Recruiting	Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifesty NCT06052345	Theodoros Foukakis	—
Recruiting	Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropath NCT06162403	M.D. Anderson Cancer Center	N/A
Completed	Symptoms Associated with Chemotherapy-Induced Peripheral Neuropathy NCT06352567	Izmir Bakircay University	—
Recruiting	Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2 NCT06139458	Duke University	N/A
Recruiting	Effects of Sensorimotor Training With Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients NCT06737926	Riphah International University	N/A
Recruiting	EGCG for the Prevention and Treatment of TIPN NCT06524609	Han Xi Zhao	Phase 1 / Phase 2
Recruiting	The Mamma HiToP Study NCT06132776	Vienna Hospital Association	N/A
Suspended	Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With NCT05751668	Alliance for Clinical Trials in Oncology	Phase 2
Recruiting	Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy NCT05840562	Institut Cancerologie de l'Ouest	Phase 3
Terminated	Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy Induced Peripheral Neuropathy (CIPN) NCT06324344	Baylor College of Medicine	N/A
Unknown	Role of Curcumin in Paclitaxel Induced PN NCT05966441	Ain Shams University	Phase 2
Completed	Effect of Transcutaneous Electrical Nerve Stimulation on CIPN Symptoms NCT06499103	Jordan University of Science and Technology	N/A
Recruiting	Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral Neu NCT05904340	National Taipei University of Nursing and Health Sciences	N/A
Active Not Recruiting	The AIUR Trial: Surgical Gloves to Prevent Peripheral Neuropathy NCT05771974	Young-Joon Kang	N/A
Completed	Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Ne NCT05935956	NeuraLace Medical, Inc.	—
Unknown	CIPN and it's Impact on Quality of Life in Patients Receiving Platinum and Taxanes NCT05829967	Assiut University	—
Unknown	Digestive Tract Cancer and CIPN NCT06331962	National Cheng-Kung University Hospital	N/A
Completed	Prediction of Getting Peripheral Neuropathy in Patients Treated With Bortezomib? NCT05781425	Odense University Hospital	—
Completed	Vincristine-induced Peripheral Neuropathy in Adult Survivors of Childhood and Adolescent Leukemia NCT05759052	University Hospital, Clermont-Ferrand	—
Unknown	The Effect of Cryotherapy on Breast Cancer Patients NCT06020222	Kaohsiung Medical University Chung-Ho Memorial Hospital	N/A
Recruiting	Photobiomodulation Therapy in the Management of Chemotherapy-Induced Peripheral Neuropathy NCT05763706	Jessa Hospital	N/A
Completed	Combined Qigong and Acupressure for Improving Chemotherapy-induced Peripheral Neuropathy NCT05764447	The University of Hong Kong	N/A
Active Not Recruiting	Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy) NCT05593614	AlgoTherapeutix	Phase 2
Recruiting	The SaVe Project-Sarcopenia and Vertigo in Aging Patients With Colorectal Cancer NCT05710809	Rigshospitalet, Denmark	N/A
Active Not Recruiting	Wearable Focal Vibration for Chemotherapy-Induced Peripheral Neuropathy NCT04959929	University of Oklahoma	N/A
Completed	The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients NCT05680870	Aya Mohamed Sadek Elsaid	Phase 3
Terminated	Exercise and Nutrition Interventions for Platinum Chemotherapy-induced Neuropathy R21 NCT05452902	University of Maryland, Baltimore	Phase 2
Recruiting	Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy NCT04763356	University of Vermont	N/A
Unknown	Qutenza Versus Duloxetine in Chemotherapy-induced Peripheral Neuropathy (CIPN) NCT05560516	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	N/A
Unknown	Use of Repetitive Transcranial Magnetic Stimulation in Cancer Patients With Chemotherapy-Induced Peripheral Ne NCT04107272	The Hong Kong Polytechnic University	N/A
Unknown	Preventing Sensory and Motor Dysfunctions in Children Receiving Neurotoxic Chemotherapy NCT05606588	University of Basel	N/A
Recruiting	Chemotherapy Induced Neuropathy in Cancer Patients NCT06491082	Swami Rama Himalayan University	—
Active Not Recruiting	A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy NCT05488873	WinSanTor, Inc	Phase 2
Recruiting	A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy - Expansion S NCT05606068	National University Hospital, Singapore	N/A
Unknown	Preventive Effect of Acetyl-L-carnitine on Oxaliplatin-induced Peripheral Neuropathy NCT05601479	Nanfang Hospital, Southern Medical University	Phase 2
Completed	Efficacy of NAC for the Prevention and Relief of PIPN in Women With Ovarian, Tubal, and Peritoneal Cancer NCT05539053	Department of Medical Services Ministry of Public Health of Thailand	N/A
Recruiting	Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Sta NCT05368428	Emory University	N/A
Completed	BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients NCT05291286	Bexion Pharmaceuticals, Inc.	EARLY_Phase 1
Completed	Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial) NCT05528263	Dana-Farber Cancer Institute	N/A
Completed	Pentoxifylline Role Against Chemotherapy-induced Neuropathy NCT06562998	Beni-Suef University	N/A
Recruiting	Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025 NCT05417737	Bernardino Clavo, MD, PhD	—
Completed	Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy NCT05388058	Mayo Clinic	Phase 2
Unknown	Transauricular Vagus Nerve Stimulation in the Treatment of Chemotherapy-induced Peripheral Neuropathy NCT05434403	Peking University People's Hospital	N/A
Active Not Recruiting	CIPN in Early Stage Breast Cancer Patients NCT05441722	Northumbria University	N/A
Terminated	Risk Prediction of Taxane Chemotherapy-Induced Peripheral Neuropathy NCT04932031	Sapere Bio	—
Active Not Recruiting	PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy NCT05246670	Academic and Community Cancer Research United	Phase 2
Completed	Hand-Foot Exercises for Chemotheraphy Induced Peripheral Neuropathy Pain, Falls and Quality of Life in Colorec NCT05873829	Gulhane Training and Research Hospital	N/A
Terminated	A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodo NCT05359133	Wex Pharmaceuticals Inc.	Phase 2
Recruiting	Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral N NCT05411523	Mayo Clinic	—
Unknown	Efficacy of Peri-neural Platelet Rich Plasma Injection in Treatment of Chemotherapy Induced Peripheral Neuropa NCT05348408	South Egypt Cancer Institute	Phase 2
Terminated	Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients NCT05251727	Veloxis Pharmaceuticals	Phase 1
Unknown	The Kinetics of Endocannabinoids in Patients With Chemotherapy Induced Peripheral Neuropathy by Using Medical NCT04376437	HaEmek Medical Center, Israel	N/A
Active Not Recruiting	Testing the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy NCT04888988	University of Rochester NCORP Research Base	N/A
Active Not Recruiting	Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy NCT05199389	Jessa Hospital	N/A
Completed	SENSE Study: Remote Symptom Monitoring for Patients With Chemotherapy-induced Peripheral Neuropathy NCT05330104	Allina Health System	N/A
Terminated	Effectiveness of Online ACT for Pain Interference in Cancer Survivors With Chronic Painful CIPN NCT05371158	Daniëlle van de Graaf	N/A
Unknown	A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy NCT05095051	National University Hospital, Singapore	N/A
Completed	Nutritional Supplement for Treating Chemotherapy Induced Neuropathy NCT07022938	Aristotle University Of Thessaloniki	Phase 4
Active Not Recruiting	The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy) NCT05121558	Dana-Farber Cancer Institute	N/A
Withdrawn	A Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-ba NCT04492436	Veloxis Pharmaceuticals	Phase 2
Recruiting	Physiologic Measure of VIPN NCT04786977	Children's National Research Institute	—
Terminated	Acupuncture for Chemo-Induced Peripheral Neuropathy in Multiple Myeloma Patients NCT04770402	Wake Forest University Health Sciences	N/A
Recruiting	Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients with Taxanes-induced Painful Peripheral Neur NCT04970121	Yan Yang, MD, Ph.D	Phase 2
Active Not Recruiting	The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropa NCT04917796	Dana-Farber Cancer Institute	N/A
Completed	Hilotherapy-study on Prevention of Oxaliplatin-induced Peripheral Neuropathy NCT04913376	Universitaire Ziekenhuizen KU Leuven	N/A
Unknown	Effect tDCS of Motor Cortex on Chemotherapy Induced Peripheral Neuropathy NCT04833920	Assiut University	N/A
Completed	Chemotherapy-induced Peripheral Neuropathy (CIPN) on Motor and Sensory Function NCT04799080	Izmir Bakircay University	—
Unknown	Cannabidiol for Prevention of Chemotherapy-induced Peripheral Neuropathy NCT04582591	Zealand University Hospital	Phase 2
Unknown	The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral Neuropathy NCT04737967	Mendel AI	Phase 2 / Phase 3
Completed	Lidocaine Versus Duloxetine for the Prevention of Taxane-Induced Peripheral Neuropathy In Breast Cancer Patien NCT04732455	Gamal Mohamed Taha Abouelmagd	N/A
Unknown	Proof of Principle Study Evaluating Gonyautoxins NEURO SERUM, on Chemotherapy-induced Peripheral Neuropathy NCT05052398	Algenis SpA	Phase 1 / Phase 2
Completed	Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer NCT04563130	Duke University	N/A
Unknown	Yiqi Wenjing Prescriptions Preventive Efficacy of Oxaliplatin-induced Peripheral Neuropathy Clinical Trial NCT04690283	Nanjing NingQi Medicine Science and Technology Co., Ltd.	Phase 3
Unknown	Effects of a Glucoside- and Rutinoside-rich Material in Chemotherapy-induced Peripheral Neuropathy and Related NCT04669977	Taipei Medical University	N/A
Recruiting	Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ) NCT04299893	Bernardino Clavo, MD, PhD	Phase 2 / Phase 3
Unknown	Drug Repurposing for the Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN) NCT04780854	Cairo University	Phase 2
Withdrawn	Lorcaserin in Treating Chemotherapy-Induced Peripheral Neuropathy in Patients With Stage I-IV Gastrointestinal NCT04205071	Ohio State University Comprehensive Cancer Center	Phase 1
Completed	Diagnostic of Chemotherapy Induced Neuropathy in Children NCT04262778	Assistance Publique - Hôpitaux de Paris	—
Completed	Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy NCT04403802	Arash Asher, MD	N/A
Completed	Effects of Transcutaneous Electrical Nerve Stimulation on Chemotherapy-Induced Peripheral Neuropathy NCT04367480	University of Rochester NCORP Research Base	N/A
Completed	Effect of Exercise in the Management of Peripheral Neuropathy NCT04843410	Istanbul University - Cerrahpasa	N/A
Unknown	A New Diagnostic Method to Assess Paclitaxel-Induced Peripheral Neuropathy NCT04237194	Carsten Dahl Mørch	—
Completed	Explored About Temperature Packing Care to Improve the Quality of Life for Chemotherapy Induced Peripheral Neu NCT06205173	National Taiwan University Hospital	N/A
Active Not Recruiting	Early Detection of Neuropathy and Cognitive Impairment Following Treatment for Haematological Malignancies NCT04393363	Aalborg University Hospital	—
Unknown	Home-Based Physical Activity Intervention for Taxane-Induced CIPN NCT04621721	University of South Florida	N/A
Terminated	Study of Nicotine for Pain Associated With Chemotherapy-Induced Peripheral Neuropathy NCT04468230	Virginia Commonwealth University	Phase 2
Recruiting	Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy NCT04560673	M.D. Anderson Cancer Center	Phase 2
Completed	Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain NCT04156802	Wake Forest University Health Sciences	N/A
Recruiting	International CIPN Assessment and Validation Study NCT04633655	University of Milano Bicocca	—
Unknown	Effect of Hemp-CBD on Patients With CIPN NCT04398446	Main Line Health	Phase 2
Withdrawn	A Study to Investigate the Safety and Efficacy of TRK-750 for the Treatment of Patients With CIPN (Chopin Stud NCT04282590	Toray Industries, Inc	Phase 2
Completed	High Tone Therapy for Chemotherapy Induced Neuropathy NCT06048471	Vienna Hospital Association	N/A
Active Not Recruiting	NIAGEN and Persistent Chemotherapy-Induced Peripheral Neuropathy NCT04112641	Donna Hammond, PhD	Phase 2
Unknown	Cryotherapy vs. Cryocompression for Preventing Chemotherapy-induced-peripheral-neuropathy in Women Undergoing NCT04632797	Medical University Innsbruck	N/A
Completed	Feasibility Study for Electroacupuncture for Chemotherapy- Induced Peripheral Neuropathy (CIPN) NCT04092764	H. Lee Moffitt Cancer Center and Research Institute	N/A
Unknown	High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy NCT04201561	Seoul National University Hospital	Phase 3
Terminated	A Mind-Body Intervention for Chemotherapy-Induced Peripheral Neuropathy NCT04185610	Arash Asher, MD	N/A
Unknown	A Feasibility Study Investigating Chemotherapy-induced Neuropathy Using Multi-frequency Tactilometry and Patie NCT04167319	Zealand University Hospital	—
Terminated	NR in Chemo-induced Peripheral Neuropathy NCT03642990	Donna Hammond, PhD	Phase 2
Terminated	Acupuncture Treatment of Chemotherapy-Induced Peripheral Neuropathy in Women NCT04067544	University of Utah	N/A
Completed	Menthol In Neuropathy Trial NCT04276727	University of Edinburgh	Phase 2
Terminated	Cryocompression Therapy for Peripheral Neuropathy in Patients With Multiple Myeloma NCT03870451	Wake Forest University Health Sciences	N/A
Completed	CIPN-prevention Trial Evaluating the Efficacy of Hand-cooling and Hand-compression NCT06541769	University Hospital Heidelberg	N/A
Withdrawn	Transcranial Direct Current Stimulation in Reducing Pain in Cancer Patients With Chemotherapy Induced Peripher NCT04135326	M.D. Anderson Cancer Center	EARLY_Phase 1
Unknown	The Role of TRP Channels in CIPN NCT04415892	Universitaire Ziekenhuizen KU Leuven	N/A
Terminated	Cannabinoids for Taxane Induced Peripheral Neuropathy NCT03782402	New York State Psychiatric Institute	Phase 2
Completed	Trial to Study Electro-Acupuncture in Subjects With Chemotherapy-Induced Peripheral Neuropathy NCT07455409	The Methodist Hospital Research Institute	N/A
Completed	Yoga for Painful Chemotherapy-Induced Peripheral Neuropathy: A Pilot, Randomized-Controlled Study NCT03824860	Dana-Farber Cancer Institute	N/A
Completed	Whole Body Vibration for the Improvement of Health and Functioning in Participants With Chemotherapy-Induced P NCT04170075	OHSU Knight Cancer Institute	N/A
Completed	Pain, Psychological, and Endocannabinoid Responses to Yoga in Breast Cancer Survivors With Chemotherapy-induce NCT04075097	University of Wisconsin, Madison	N/A
Unknown	Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY) NCT03997981	Disarm Therapeutics	—
Unknown	Comparing Lorcaserin Versus Duloxetine for the Treatment of Chemotherapy-Induced Peripheral Neuropathy NCT03812523	Southeastern Regional Medical Center	Phase 2
Completed	Fingolimod in Treating Patients With Chemotherapy-Induced Neuropathy NCT03943498	Mayo Clinic	EARLY_Phase 1
Suspended	Playful Sensorimotor Training in Pediatric Brain Tumor Patients NCT03334162	University of Basel	N/A
Completed	Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic Pain NCT04239976	M.D. Anderson Cancer Center	N/A
Completed	Validation of the PNQ for CIPN Patients. NCT04773379	Democritus University of Thrace	—
Completed	Involvement of SK3 Calcium Channel in Taxane Neuropathy NCT03816904	University Hospital, Tours	—
Completed	Prevalence, Intensity and Consequences of Bortezomib-induced Neuropathic Disorders. NCT03344328	University Hospital, Clermont-Ferrand	—
Completed	Evaluation by Oncologists of Strategies for the Prevention and Treatment of Chemotherapy-induced Peripheral Ne NCT03854864	University Hospital, Clermont-Ferrand	—
Terminated	Preventive Treatment of OxaLiplatin Induced peripherAl neuRopathy in Adjuvant Colorectal Cancer NCT04034355	Egetis Therapeutics	Phase 3
Completed	Spinal Cord Stimulation in Chemotherapy Induced Neuropathy NCT03764514	Prisma Health-Upstate	—
Terminated	Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M) NCT03654729	Egetis Therapeutics	Phase 3
Completed	Acupuncture for Chemotherapy-induced Peripheral Neuropathy NCT03582423	Hong Kong Baptist University	N/A
Recruiting	Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer NCT06490159	City of Hope Medical Center	—
Completed	A New Method for Identifying Sensory Changes in Painful Chemotherapy-induced Peripheral Neuropathy (CIPN) NCT03687970	Washington University School of Medicine	N/A
Completed	Acupuncture on Chemotherapy-induced Peripheral Neuropathy NCT03626220	China Medical University Hospital	N/A
Completed	Clinician Decision Support Algorithm for Chemotherapy-Induced Peripheral Neuropathy NCT03514680	Dana-Farber Cancer Institute	N/A
Completed	Somatic Yoga and Meditation for Cancer Survivors With Pain From Neuropathy NCT03786055	Stockton University	N/A
Completed	The Preliminary Effects of Henna on CIPN NCT04201587	Selcuk University	N/A
Completed	Integrative Medicine for Chemotherapy-Induced Peripheral Neuropathy NCT03290976	The Chaim Sheba Medical Center	N/A
Unknown	The Exploratory Study of Electroacupuncture in the Treatment of Peripheral Neuropathy Induced by Platinum Base NCT03048591	Tianjin Medical University Cancer Institute and Hospital	N/A
Completed	Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy NCT03909464	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	—
Unknown	Visualize Nociceptor Changes in Neuropathic Human NCT03112057	National Taiwan University Hospital	N/A
Completed	Chemotherapy Induced Peripheral Neuropathy (CIPN) NCT03272919	Loma Linda University	N/A
Completed	Lidocaine for Oxaliplatin-induced Neuropathy NCT03254394	Washington University School of Medicine	Phase 1 / Phase 2
Completed	Acupuncture for Symptoms of Nerve Damage NCT03183037	Memorial Sloan Kettering Cancer Center	N/A
Completed	Objective Evaluation of Paclitaxel/Docetaxel-induced Neuropathy in Breast Cancer Patients NCT03872141	Yale University	—
Unknown	Whole-body Vibration Training to Reduce the Symptoms of Chemotherapy-induced Peripheral Neuropathy NCT03032718	University of Basel	N/A
Completed	Impact of an Orthotic Intervention in Children With Peripheral Neuropathy NCT03655587	Children's Hospitals and Clinics of Minnesota	N/A
Completed	Memantine XR and Pregabalin for Chemotherapy-Induced Peripheral Neuropathy NCT03709888	Saint John's Cancer Institute	—
Completed	Using Game-based Exercise to Improve Balance in Cancer Patients NCT02773329	Baylor College of Medicine	Phase 2
Completed	Exercises for Patients Who Were Receiving Chemotherapy NCT03798379	Hitit University	N/A
Completed	The Effectiveness and Cost-effectiveness of Acupuncture in Managing Chemotherapy-induced Peripheral Neuropathy NCT02553863	The Hong Kong Polytechnic University	N/A
Terminated	Dextromethorphan in Chemotherapy-induced Peripheral Neuropathy Management NCT02271893	University Hospital, Clermont-Ferrand	Phase 2
Completed	Photobiomodulation Therapy Using the Realief Therapy System for the Treatment of Chemotherapy-associated Perip NCT02000908	University of Minnesota	N/A
Completed	Effects of Massage Therapy on Peripheral Neuropathy and Quality of Life NCT05433246	Fatma Arikan	N/A
Withdrawn	Chemotherapy-Induced Peripheral Neuropathy Survey NCT01016028	M.D. Anderson Cancer Center	—
Completed	Effect of TRO19622 in the Treatment of Patients With Chemotherapy Induced Peripheral Neuropathy NCT00876538	Hoffmann-La Roche	Phase 2
Terminated	Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Ca NCT00380874	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4
Completed	Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy NCT00041795	NeoTherapeutics	Phase 2